Hanmi Pharm, Stock Price 379,000 KRW (4.7%)... Bulletin Board 'Bustling'

At this time, posts about Hanmi Pharm are rapidly increasing on portals and securities communities. Today, foreigners have sold a net 10,000 shares of Hanmi Pharm, and institutions have sold a net 4,000 shares, according to provisional data. Hanmi Pharm is known as a pharmaceutical company specializing in the production of prescription drugs.

As of 1:30 PM on the 6th, Hanmi Pharm's stock price is 379,000 KRW, up 4.7% from the previous day, with a trading volume of 558,115 shares, which is 340.12% of the average trading volume over the past five days. On December 30th, Hanmi Pharm was a market issue due to "strong performance on expectations of COVID-19 vaccine contract manufacturing."

In addition to Hanmi Pharm, posts by investors are also rapidly increasing for Intergis (129260), SNK (950180), and DB HiTek (000990).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.